A retrotransposon-derived DNA zip code internalizes myeloma cells through Clathrin-Rab5a-mediated endocytosis.

Publication Year: 2024

DOI:
10.3389/fonc.2024.1288724

PMCID:
PMC10920344

PMID:
38463228

Journal Information

Full Title: Front Oncol

Abbreviation: Front Oncol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Oncology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest PP, LM-M, LF, and AP are employees and equity holders of Kodikaz Therapeutic Solutions. AJ and LB-M are co-founders and equity holders of Kodikaz Therapeutic Solutions. The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."

Evidence found in paper:

"The author(s) declare financial support was received for the research, authorship, and/or publication of this article. Funding is provided by the private investors to Kodikaz Therapeutic Solutions. We acknowledge the partial funding support from Georgia Research Alliance, Award ID: 0000060921. Award Reference: GRA.VL20.C1"

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025